ReviewFrontiers in oncology2022

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.

Yingying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.